2023 SCPC Summit Recap
In late July, the Senior Care Pharmacy Coalition (SCPC) gathered in Washington, D.C. for our annual Business Partners Summit where we discussed key issues and policies impacting the long-term care (LTC) pharmacy community and the unique role our members play in America’s healthcare system.
The Summit brought together SCPC member companies, LTC pharmacy business partners, healthcare industry analysts and policy experts along with several prominent members of Congress for a broad discussion on the important role LTC pharmacies play in providing quality care for nearly two million seniors and those with disabilities.
The SCPC team wrapped up this year’s Summit with great enthusiasm after welcoming a record number of attendees, networking with peers, and engaging in substantive discussions about key issues impacting the LTC community and ways we can work together to enact meaningful policy reforms to improve access to care.
Our team, members and stakeholders move forward from the Summit with a renewed focus on our core missions: meeting the unique pharmacy needs of those we serve, improving health outcomes through innovative service, and ensuring the best possible environment for LTC pharmacies to operate. To do that, we are focused on four major issues that will guide our ongoing efforts, including:
–Advocating for Meaningful PBM Reform in 2023. Pharmacy benefit managers (PBMs) are driving up the cost of medicines and reducing access to care while attempting to drive community and LTC pharmacies out of business. Learn More.
–Protecting LTC Pharmacies from Drug Price Negotiations. As part of the Inflation Reduction Act (IRA), CMS will soon begin negotiating prices for some of the most expensive prescription drugs, many of which are routinely dispensed by LTC pharmacies serving Medicare Part D patients. Without important reforms to ensure proper reimbursements and to stop PBMs from steering patients to their own affiliated pharmacies, the IRA’s price setting policies will disrupt the market and put LTC pharmacies the unique patient population we serve at significant risk. Learn More.
–Improving Access to Long-Term Care Pharmacy Services at Home. LTC pharmacies are uniquely positioned to provide specialized pharmacy services in a variety of different settings, including home-based care. Learn More.
–Defining and Properly Recognizing LTC Pharmacies at the Federal Level. Current federal regulations impose conflicting and confusing obligations on LTC pharmacies that hamper our ability to provide care to the unique population we serve. Learn More.
Addressing these priority issues with sensible and innovative reforms will have a major impact on the LTC pharmacy community’s ability to effectively serve one of our nation’s most vulnerable patient populations. We look forward to sharing more information on these important topics throughout the remainder of the year.
For now, we thank our members, business partners, analysts and experts for taking part in this year’s SCPC Business Partners Summit. Please check out the photos of the Summit here. We look forward to gathering again in July of 2024.






*Right click on an individual image to save to desktop for use
Recent Posts
-
Senior Care Pharmacy Coalition Applauds Chairman Comer and House Oversight Committee for Shedding Light on Harmful PBM Practices, Encourages Congress to Advance PBM Reform Legislation Heard Today in House Energy and Commerce Committee Health Subcommittee
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care pharmacy community, released a statement today regarding the House Oversight Committee’s hearing on pharmacy benefit managers.
-
Stuck in the middle, LTC pharmacies could be dangerously squeezed by drug price negotiations
Any lower drug prices that result from White House efforts to negotiate on behalf of Medicare beneficiaries may lead to short-term gains for nursing homes, but there also could be a steep price to pay in the long-term, experts warned this week. The Centers for Medicare & Medicaid Services on Tuesday announced the first 10 drugs covered by Medicare Part D that will be included in negotiations running through 2024. They are all commonly prescribed drugs that treat conditions ranging from diabetes to arthritis and heart failure.
-
Biden’s Plans to Reduce Cost of Medicare Drugs To Send Ripple Effects Through Nursing Home Industry
Following the Biden Administration’s bid this week to reduce the price of certain drugs – many of which are commonly used in nursing homes – experts are cautioning that the changes may negatively impact the bottomline of organizations in the sector. As Medicare Part D price negotiations for these drugs come into focus this week, the Senior Care Pharmacy Coalition (SCPC), for one, is warning that changes to Part D might cause “collateral damage” to long-term care pharmacies, the patients they serve and operator partners.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.